I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...

The heritage of Boehringer Ingelheim in developing medicines for ... spanning almost 100 years of innovation in drug and device development – there is continuing medical need for therapies ...

Therefore, the treatment can be combined with other activities on the device like games or watching movies.” Dr Oliver Reuß, executive director and investment manager of Boehringer Ingelheim Ve ...

Tiotropium (as bromide monohydrate) 18mcg/cap; dry pwd in caps for oral inhalation; with inhaler device. Spiriva Handihaler consists of Spiriva capsules and the Handihaler device. Spiriva capsules ...

Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, ...

The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...

Find out why Boehringer, Amgen and Novartis have been awarded the highest reputation scores by several cardiovascular patient ...

INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal ...

Hello Health Rounds Readers! Today we have three studies presented at medical meetings, including one testing a device that ...

A new survey shows that three Big Pharmas have stolen the hearts of patient groups representing nearly 1 million people with cardiovascular conditions. | A new survey shows that three Big Pharmas have ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...